The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
Open accessAbstract
Purpose: Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide. Incidence rates are increasing in the United States. Monitoring incidence, survival, and mortality rates within at-risk populations can facilitate control efforts. Methods: Age-adjusted incidence trends for HCC were examined in the Surveillance, Epidemiology, and End Results (SEER) registries from 1975 to 2005. Age-specific rates were examined for birth cohorts born between 1900 and 1959. Age-adjusted incidence and cause-specific survival rates from 1992 to 2005 were examined in the SEER 13 registries by race/ethnicity, stage, and treatment. United States liver cancer mortality rates were also examined. Results: Age-adjusted HCC incidence rates tripled between 1975 and 2005. Incidence rates increased in each 10-year birth cohort from 1900 through the 1950s. Asians/Pacific Islanders had higher incidence and mortality rates than other racial/ethnic groups, but experienced a significant decrease in mortality rates over time. From 2000 to 2005, marked increases in incidence rates occurred among Hispanic, black, and white middle-aged men. Between 1992 and 2004, 2- to 4-year HCC survival rates doubled, as more patients were diagnosed with localized and regional HCC and prognosis improved, particularly for patients with reported treatment. Recent 1-year survival rates remained, however, less than 50%. Conclusion: HCC incidence and mortality rates continue to increase, particularly among middle-aged black, Hispanic, and white men. Screening of at-risk groups and treatment of localized-stage tumors may contribute to increasing HCC survival rates in the United States. More progress is needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Permutation tests for joinpoint regression with applications to cancer rates
Kim, H.-J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z · Cited by 6,318
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,805
Estimating the world cancer burden: Globocan 2000
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2001) · International Journal of Cancer · doi:10.1002/ijc.1440 · Cited by 3,721
Llovet, J. M., Burroughs, A., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,608
The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00004 · Cited by 1,955
(1998) · PsycEXTRA Dataset · doi:10.1037/e547602006-001 · Cited by 1,213
Diagnosis and Treatment of Hepatocellular Carcinoma
El-Serag, H. B., Marrero, J. A., Rudolph, L., & Reddy, K. R. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.090 · Cited by 1,137
[Gastric adenocarcinoma and kidney transplantation].
Barrio, J., García-Bengoechea, M., Emparanza, J. I., & Arenas, J. I. (1998) · PubMed · Cited by 1,132
Molecular targeted therapies in hepatocellular carcinoma†
Llovet, J. M., & Bruix, J. (2008) · Hepatology · doi:10.1002/hep.22506 · Cited by 1,004
The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update
El-Serag, H. B., Davila, J. A., Petersen, N. J., & McGlynn, K. A. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00009 · Cited by 943
Self-citationKim, H. (2001) · Statistics in Medicine · doi:10.1002/sim.811 · Cited by 873
El–Serag, H. B., Hampel, H., & Javadi, F. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.12.007 · Cited by 826
Alcohol and hepatocellular carcinoma
Morgan, T. R., Mandayam, S., & Jamal, M. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.020 · Cited by 625
Espey, D. K., Wu, X., Swan, J., Wiggins, C., Jim, M. A., Ward, E., Wingo, P. A., Howe, H. L., Ries, L. A. G., Miller, B. A., et al. (2007) · Cancer · doi:10.1002/cncr.23044 · Cited by 576
Surveillance for acute viral hepatitis--United States, 2006.
Wasley, A., Grytdal, S., & Gallagher, K. (2008) · PubMed · Cited by 535
Davila, J. A., Morgan, R. O., Shaib, Y., McGlynn, K. A., & El–Serag, H. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.020 · Cited by 501
Self-citationObesity and hepatocellular carcinoma
Caldwell, S. H., Crespo, D. M., Kang, H. S., & Al-Osaimi, A. M. S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.021 · Cited by 396
Surveillance for acute viral hepatitis--United States, 2005.
Wasley, A., Miller, J. T., & Finelli, L. (2007) · PubMed · Cited by 392
Hepatocellular carcinoma: Recent trends in Japan
Kiyosawa, K., Umemura, T., Ichijo, T., Matsumoto, A., Yoshizawa, K., Gad, A., & Tanaka, E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.012 · Cited by 308
Chan, H. L.-Y., Tse, C.-H., Mo, F., Koh, J., Wong, V. W.-S., Wong, G. L.-H., Lam Chan, S., Yeo, W., Sung, J. J.-Y., & Mok, T. S.-K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.2043 · Cited by 301
Impact of Reporting Delay and Reporting Error on Cancer Incidence Rates and Trends
Clegg, L. X. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.20.1537 · Cited by 278
El-Serag, H. B., Siegel, A. B., Davila, J. A., Shaib, Y. H., Cayton-Woody, M., McBride, R., & McGlynn, K. A. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.002 · Cited by 232
Self-citationThe epidemiology of hepatitis C infection in the United States
Rustgi, V. K. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-007-2064-6 · Cited by 188
Misclassification of race/ethnicity in a population-based cancer registry (United States)
Gomez, S. L., & Glaser, S. L. (2006) · Cancer Causes & Control · doi:10.1007/s10552-006-0013-y · Cited by 167 · cited 1×
“Point estimates and ranges of percent foreign birth were determined for racial/ethnic groups based on completeness of data.(14) Annual age-adjusted HCC incidence rates were examined from 1975 to 2005.”
MethodCapocaccia, R., Sant, M., Berrino, F., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01337.x · Cited by 138
Epidemiology of Hepatocellular Carcinoma in Hispanics in the United States
El‐Serag, H. B., Lau, M., Eschbach, K., Davila, J. A., & Goodwin, J. S. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.18.1983 · Cited by 137
Sloane, D. A., Chen, H., & Howell, C. D. (2006) · PubMed · Cited by 123
Ko, C. W., Siddaiah, N. B., Berger, J., Gish, R. G., Brandhagen, D. J., Sterling, R. K., Cotler, S. J., Fontana, R. J., McCashland, T. M., Han, S. H. B., et al. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01596.x · Cited by 99
Chronic Viral Hepatitis and Hepatocellular Carcinoma
Barazani, Y., Hiatt, J. R., Tong, M. J., et al. (2007) · World Journal of Surgery · doi:10.1007/s00268-007-9041-3 · Cited by 98
London, W. T., & McGlynn, K. A. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195149616.003.0039 · Cited by 93
Self-citationNational trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003.
Ahmed, F., Perz, J. F., Kwong, S. L., Jamison, P. M., Friedman, C., & Bell, B. P. (2008) · PubMed Central · Cited by 79
Hu, K. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01878.x · Cited by 68
Injection Drug Users: The Overlooked Core of the Hepatitis C Epidemic
Edlin, B. R., & Carden, M. R. (2006) · Clinical Infectious Diseases · doi:10.1086/499960 · Cited by 66
Hepatitis B awareness, knowledge, and screening among Asian Americans
Nguyen, T. T., Taylor, V., Chen, M. S., Bastani, R., Maxwell, A. E., & McPhee, S. J. (2007) · Journal of Cancer Education · doi:10.1007/bf03174128 · Cited by 65
Liver cancer in Asian migrants to the United States and their descendants
Rosenblatt, K. A., Weiss, N. S., & Schwartz, S. M. (1996) · Cancer Causes & Control · doi:10.1007/bf00052940 · Cited by 58
Cited by
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Yang, J. D., Hainaut, P., Gores, G. J., Amadou, A., Plymoth, A., & Roberts, L. R. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0186-y · Cited by 4,228
Global Cancer Incidence and Mortality Rates and Trends—An Update
Torre, L. A., Siegel, R. L., Ward, E. M., & Jemal, A. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0578 · Cited by 3,692
Global patterns of cancer incidence and mortality rates and trends
Jemal, A., Center, M. M., DeSantis, C., & Ward, E. M. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0437 · Cited by 2,778
Metadata
- Authors
- Altekruse, S. F., McGlynn, K. A., & Reichman, M. E.
- Venue
- Journal of Clinical Oncology
- Published
- 2009-03-20
- Volume
- 27
- Issue
- 9
- Pages
- 1485-1491
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2138424758
- Cited by
- 1,694
- References
- 39
- FWCI
- 61.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.